Table. 1.

Characteristics of the Patients

Characteristic Group 1 (n = 30) Group 2 (n = 30) P value
Age (yr) 59.7 ± 2.8 58.7 ± 2.5 0.150
Sex 1.000
M 25 (83.3) 25 (83.3)
F 5 (16.7) 5 (16.7)
ASA-PS 0.290
I 3 (10.0) 4 (13.3)
II 21 (70.0) 11 (36.7)
III 6 (20.0) 15 (50.0)
Body mass ─▒ndex (kg/m2) 27.9 ± 3.9 27.2 ± 3.4 0.462
Duration of anesthesia (min) 53.3 ± 21.5 38.0 ± 17.8 0.004
Duration of surgery (min) 41.5 ± 18.8 30.7 ± 14.6 0.150
Dose of intraoperative remifentanil (μg/kg/hr) 7.3 ± 5.1 7.1 ± 4.9 0.877
Urinary catheter size 1.000
< 18 Fr 1 0
18 Fr 4 5
19 Fr 14 13
20 Fr 11 12

Values are presented as mean ± standard deviation, number (%), or number only.

Group 1: the atropine group, group 2: sugammadex group, ASA-PS: American Society of Anesthesiologists-Physical Status.

Korean J Pain 2020;33:176~182 https://doi.org/10.3344/kjp.2020.33.2.176
© Korean J Pain